glp 1 generic drugs As GLP-1 Drug Shortage Ends, Why Will Patients Pay More? glp 1 drug names list
Description
2020;76(3 Suppl 1):S1107
As demonstrated in a recent meta-analysis, SGLT-2i treatment is associated with increased plasma fasting glucagon levels in patients with diabetes compared with non-SGLT-2i treatments with a reduction of insulin and increased ketone body levels (91)
The counter-argument is that mechanistic evidence is strong, multiple lines of clinical evidence converge, and the risk profile at microdose levels is favorable
[1] When considering GLP-1 side effects, it is best to consult your doctor about the individual GLP-1 medication they prescribed
